RESUMO
Primary human CoQ(10) deficiencies are clinically heterogeneous diseases caused by mutations in PDSS2 and other genes required for CoQ(10) biosynthesis. Our in vitro studies of PDSS2 mutant fibroblasts, with <20% CoQ(10) of control cells, revealed reduced activity of CoQ(10)-dependent complex II+III and ATP synthesis, without amplification of reactive oxygen species (ROS), markers of oxidative damage, or antioxidant defenses. In contrast, COQ2 and ADCK3 mutant fibroblasts, with 30-50% CoQ(10) of controls, showed milder bioenergetic defects but significantly increased ROS and oxidation of lipids and proteins. We hypothesized that absence of oxidative stress markers and cell death in PDSS2 mutant fibroblasts were due to the extreme severity of CoQ(10) deficiency. Here, we have investigated in vivo effects of Pdss2 deficiency in affected and unaffected organs of CBA/Pdss2(kd/kd) mice at presymptomatic, phenotypic-onset, and end-stages of the disease. Although Pdss2 mutant mice manifest widespread CoQ(9) deficiency and mitochondrial respiratory chain abnormalities, only affected organs show increased ROS production, oxidative stress, mitochondrial DNA depletion, and reduced citrate synthase activity, an index of mitochondrial mass. Our data indicate that kidney-specific loss of mitochondria triggered by oxidative stress may be the cause of renal failure in Pdss2(kd/kd) mice.
Assuntos
Alquil e Aril Transferases/deficiência , Alquil e Aril Transferases/genética , Mitocôndrias/metabolismo , Ubiquinona/deficiência , Difosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , DNA Mitocondrial/genética , DNA Mitocondrial/metabolismo , Transporte de Elétrons , Fibroblastos/metabolismo , Humanos , Rim/metabolismo , Rim/patologia , Camundongos , Camundongos Endogâmicos CBA , Camundongos Mutantes , Estresse Oxidativo , Distribuição TecidualRESUMO
A 25-year-old man with exertional myoglobinuria had no evidence of hemolytic anemia, but he had severe parkinsonism that was responsive to levodopa. Phosphoglycerate kinase (PGK) activity was markedly decreased in muscle, and molecular analysis of the PGK1 gene identified the p.T378P mutation that was recently reported in a patient with isolated myopathy. This case reinforces the concept that PGK deficiency is a clinically heterogeneous disorder and raises the question of a relationship between PGK deficiency and idiopathic juvenile Parkinson disease.
Assuntos
Doenças Metabólicas/enzimologia , Doenças Musculares/enzimologia , Transtornos Parkinsonianos/enzimologia , Fosfoglicerato Quinase/deficiência , Adulto , Idade de Início , Encefalopatias Metabólicas Congênitas/complicações , Encefalopatias Metabólicas Congênitas/enzimologia , Encefalopatias Metabólicas Congênitas/genética , Causalidade , Análise Mutacional de DNA , Regulação Enzimológica da Expressão Gênica/genética , Marcadores Genéticos , Predisposição Genética para Doença/genética , Genótipo , Humanos , Masculino , Doenças Metabólicas/complicações , Doenças Metabólicas/genética , Músculo Esquelético/embriologia , Músculo Esquelético/fisiopatologia , Doenças Musculares/genética , Doenças Musculares/fisiopatologia , Mutação/genética , Mioglobinúria/enzimologia , Mioglobinúria/etiologia , Mioglobinúria/fisiopatologia , Transtornos Parkinsonianos/genética , Transtornos Parkinsonianos/fisiopatologia , Fosfoglicerato Quinase/genéticaRESUMO
Coenzyme Q(10) (CoQ(10)) is essential for electron transport in the mitochondrial respiratory chain and antioxidant defense. Last year, we reported the first mutations in CoQ(10) biosynthetic genes, COQ2, which encodes 4-parahydroxybenzoate: polyprenyl transferase; and PDSS2, which encodes subunit 2 of decaprenyl diphosphate synthase. However, the pathogenic mechanisms of primary CoQ(10) deficiency have not been well characterized. In this study, we investigated the consequence of severe CoQ(10) deficiency on bioenergetics, oxidative stress, and antioxidant defenses in cultured skin fibroblasts harboring COQ2 and PDSS2 mutations. Defects in the first two committed steps of the CoQ(10) biosynthetic pathway produce different biochemical alterations. PDSS2 mutant fibroblasts have 12% CoQ(10) relative to control cells and markedly reduced ATP synthesis, but do not show increased reactive oxygen species (ROS) production, signs of oxidative stress, or increased antioxidant defense markers. In contrast, COQ2 mutant fibroblasts have 30% CoQ(10) with partial defect in ATP synthesis, as well as significantly increased ROS production and oxidation of lipids and proteins. On the basis of a small number of cell lines, our results suggest that primary CoQ(10) deficiencies cause variable defects of ATP synthesis and oxidative stress, which may explain the different clinical features and may lead to more rational therapeutic strategies.
Assuntos
Transporte de Elétrons/fisiologia , Estresse Oxidativo , Ubiquinona/análogos & derivados , Trifosfato de Adenosina/biossíntese , Antioxidantes , Células Cultivadas , Complexo de Proteínas da Cadeia de Transporte de Elétrons , Fibroblastos/citologia , Fibroblastos/metabolismo , Mutação , Espécies Reativas de Oxigênio , Ubiquinona/deficiênciaRESUMO
BACKGROUND: The number of molecular causes of MELAS (a syndrome consisting of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) and Leigh syndrome (LS) has steadily increased. Among these, mutations in the ND5 gene (OMIM 516005) of mitochondrial DNA are important, and the A13513A change has emerged as a hotspot. OBJECTIVE: To describe the clinical features, muscle pathological and biochemical characteristics, and molecular study findings of 12 patients harboring the G13513A mutation in the ND5 gene of mitochondrial DNA compared with 14 previously described patients with the same mutation. DESIGN: Clinical examinations and morphological, biochemical, and molecular analyses. SETTING: Tertiary care university hospital and molecular diagnostic laboratory. PATIENTS: Three patients had the typical syndrome features of MELAS; the other 9 had typical clinical and radiological features of LS. RESULTS: Family history suggested maternal inheritance in a few cases; morphological studies of muscle samples rarely showed typical ragged-red fibers and more often exhibited strongly succinate dehydrogenase-reactive blood vessels. Biochemically, complex I deficiency was inconsistent and generally mild. The mutation load was relatively high in the muscle and blood specimens. CONCLUSION: The G13513A mutation is a common cause of MELAS and LS, even in the absence of obvious maternal inheritance, pathological findings in muscle, or severe complex I deficiency.
Assuntos
DNA Mitocondrial/genética , Complexo I de Transporte de Elétrons/genética , Doença de Leigh/genética , Síndrome MELAS/genética , Proteínas Mitocondriais/genética , Mutação/genética , Adulto , Pré-Escolar , Análise Mutacional de DNA , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Saúde da Família , Feminino , Humanos , Lactente , Doença de Leigh/patologia , Síndrome MELAS/patologia , Masculino , Pessoa de Meia-Idade , Músculo Liso Vascular/metabolismo , Succinato Desidrogenase/metabolismoRESUMO
A 6-year-old boy had progressive muscle weakness since age 4 and emotional problems diagnosed as Asperger syndrome. His mother and two older siblings are in good health and there is no family history of neuromuscular disorders. Muscle biopsy showed ragged-red and cytochrome coxidase (COX)-negative fibers. Respiratory chain activities were reduced for all enzymes containing mtDNA-encoded subunits, especially COX. Sequence analysis of the 22 tRNA genes revealed a novel G10406A base substitution, which was heteroplasmic in multiple tissues of the patient by RFLP analysis (muscle, 96%; urinary sediment, 94%; cheek mucosa, 36%; blood, 29%). The mutation was not detected in any accessible tissues from his mother or siblings. It appears that this mutation arose de novo in the proband, probably early in embryogenesis.
Assuntos
DNA Mitocondrial/genética , Miopatias Mitocondriais/genética , RNA de Transferência de Arginina/genética , Substituição de Aminoácidos , Síndrome de Asperger/complicações , Criança , Humanos , Masculino , Miopatias Mitocondriais/complicações , Miopatias Mitocondriais/patologia , Conformação de Ácido Nucleico , Linhagem , Polimorfismo de Fragmento de Restrição , RNA de Transferência de Arginina/químicaRESUMO
A 14-year-old boy had exercise intolerance, weakness, ataxia, and lactic acidosis. Because his muscle biopsy showed a mosaic pattern of fibers staining intensely with the succinate dehydrogenase reaction but not at all with the cytochrome c oxidase reaction, we sequenced his mitochondrial DNA and found a novel mutation (C14680A) in the gene for tRNAGlu. The mutation was present in accessible tissues from the asymptomatic mother but not from a brother with Asperger syndrome. These data expand the clinical heterogeneity of mutations in this mitochondrial gene.
Assuntos
Deficiência de Citocromo-c Oxidase/genética , DNA Mitocondrial/genética , Encefalomiopatias Mitocondriais/genética , Músculo Esquelético/metabolismo , RNA de Transferência de Ácido Glutâmico/genética , Adolescente , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Humanos , Masculino , Encefalomiopatias Mitocondriais/metabolismo , Encefalomiopatias Mitocondriais/patologia , Músculo Esquelético/patologia , Mutação , Polimorfismo de Nucleotídeo Único , RNA de Transferência de Ácido Glutâmico/metabolismoRESUMO
SUCLA2 defects have been associated with mitochondrial DNA (mtDNA) depletion and the triad of hypotonia, dystonia/Leigh-like syndrome, and deafness. A 9-year-old Brazilian boy of consanguineous parents presented with psychomotor delay, deafness, myopathy, ataxia, and chorea. Despite the prominent movement disorder, brain magnetic resonance imaging (MRI) was normal while 1H-magnetic resonance spectroscopy (MRS) showed lactate peaks in the cerebral cortex and lateral ventricles. Decreased biochemical activities of mitochondrial respiratory chain enzymes containing mtDNA-encoded subunits and mtDNA depletion were observed in muscle and fibroblasts. A novel homozygous mutation in SUCLA2, the first one in the ligase coenzyme A (CoA) domain of the protein, was identified. Escalating doses of CoQ10 up to 2000 mg daily were associated with improvement of muscle weakness and stabilization of the disease course. The findings indicate the importance of screening for mitochondrial dysfunction in patients with complex movement disorders without brain MRI lesions and further investigation for potential secondary CoQ10 deficiency in patients with SUCLA2 mutations.
Assuntos
Transtornos dos Movimentos/genética , Mutação , Succinato-CoA Ligases/genética , Ataxia/diagnóstico , Ataxia/genética , Ataxia/patologia , Ataxia/terapia , Encéfalo/diagnóstico por imagem , Encéfalo/metabolismo , Criança , Diagnóstico Diferencial , Homozigoto , Humanos , Masculino , Doenças Mitocondriais/diagnóstico , Doenças Mitocondriais/genética , Doenças Mitocondriais/patologia , Doenças Mitocondriais/terapia , Transtornos dos Movimentos/diagnóstico , Transtornos dos Movimentos/patologia , Transtornos dos Movimentos/terapia , Debilidade Muscular/diagnóstico , Debilidade Muscular/genética , Debilidade Muscular/patologia , Debilidade Muscular/terapia , Músculo Esquelético/patologia , Ubiquinona/deficiência , Ubiquinona/genéticaRESUMO
BACKGROUND: Mitochondrial DNA depletion syndrome is an autosomal recessive disorder characterized by decreased mitochondrial DNA copy numbers in affected tissues. It has been linked to 4 genes involved in deoxyribonucleotide triphosphate metabolism: thymidine kinase 2 (TK2), deoxyguanosine kinase (DGUOK), polymerase gamma (POLG), and SUCLA2, the gene encoding the beta-subunit of the adenosine diphosphate-forming succinyl coenzyme A synthetase ligase. OBJECTIVE: To highlight the variability in the clinical spectrum of TK2-related mitochondrial DNA depletion syndrome. DESIGN: Review of patients and the literature. SETTING: Tertiary care university. PATIENTS: Four patients with mitochondrial DNA depletion syndrome and mutations in the TK2 gene. MAIN OUTCOME MEASURES: Definition of clinical variability. RESULTS: Patient 1 had evidence of lower motoneuron disease and was initially diagnosed as having spinal muscular atrophy type 3. Patient 2, who is alive and ambulatory at age 9 years, presented at age 2 years with a slowly progressive mitochondrial myopathy. Patient 3 had a more severe myopathy, with onset in infancy and death at age 6 years of respiratory failure. Patient 4 had a rapidly progressive congenital myopathy with rigid spine syndrome and he died at age 19 months. CONCLUSION: The clinical spectrum of TK2 mutations is not limited to severe infantile myopathy with motor regression and early death but includes spinal muscular atrophy type 3-like presentation, rigid spine syndrome, and subacute myopathy without motor regression and with longer survival.
Assuntos
DNA Mitocondrial/genética , DNA Mitocondrial/metabolismo , Doenças Mitocondriais/enzimologia , Doenças Mitocondriais/genética , Mutação , Timidina Quinase/genética , Adolescente , Criança , Feminino , Humanos , Lactente , Masculino , Doenças Mitocondriais/patologia , Timidina Quinase/metabolismoRESUMO
Cockayne syndrome and xeroderma pigmentosum-Cockayne syndrome complex are rare autosomal recessive disorders with poorly understood biology. They are characterized by profound postnatal brain and somatic growth failure and by degeneration of multiple tissues resulting in cachexia, dementia, and premature aging. They result in premature death, usually in childhood, exceptionally in adults. This study compares the clinical course and pathology of a man with Cockayne syndrome group A who died at age 31(1/2) years with 15 adequately documented other adults with Cockayne syndrome and 5 with xeroderma pigmentosum-Cockayne syndrome complex. Slowing of head and somatic growth was apparent before age 2 years, mental retardation and slowly progressive spasticity at 4 years, ataxia and hearing loss at 9 years, visual impairment at 14 years, typical Cockayne facies at 17 years, and cachexia and dementia in his twenties, with a retained outgoing personality. He experienced several transient right and left hemipareses and two episodes of status epilepticus following falls. Neuropathology disclosed profound microencephaly, bilateral old subdural hematomas, white-matter atrophy, tigroid leukodystrophy with string vessels, oligodendrocyte proliferation, bizarre reactive astrocytes, multifocal dystrophic calcification that was most marked in the basal ganglia, advanced atherosclerosis, mixed demyelinating and axonal neuropathy, and neurogenic muscular atrophy. Cellular degeneration of the organ of Corti, spiral and vestibular ganglia, and all chambers of the eye was severe. Rarely, and for unexplained reasons, in some patients with Cockayne syndrome the course is slower than usual, resulting in survival into adulthood. The profound dwarfing, failure of brain growth, cachexia, selectivity of tissue degeneration, and poor correlation between genotypes and phenotypes are not understood. Deficient repair of DNA can increase vulnerability to oxidative stress and play a role in the premature aging, but why patients with mutations in xeroderma pigmentosum genes present with the Cockayne syndrome phenotype is still not known.
Assuntos
Síndrome de Cockayne/patologia , Síndrome de Cockayne/fisiopatologia , Adulto , Encéfalo/patologia , Círculo Arterial do Cérebro/patologia , Síndrome de Cockayne/genética , Evolução Fatal , Humanos , Imageamento por Ressonância Magnética , MasculinoRESUMO
Three patients with different clinical phenotypes harbored the same point mutation at nucleotide 14709 (T14709C) in the tRNAGlu gene of mitochondrial DNA (mtDNA). The first patient was a 21-month-old child with severe congenital myopathy, respiratory distress and mild mental retardation. Muscle biopsy showed about 12% cytochrome c oxidase (COX)-negative ragged-red fibers (RRFs), and markedly decreased activities of mitochondrial respiratory chain complexes I, III and IV. The other two patients were 51- and 55-year-old siblings with slowly progressive myopathy and diabetes mellitus. Muscle biopsy showed focal COX-negative RRFs and decreased activities of complexes I, III and IV. In all three patients, the T14709C mutation was abundant in muscle but present at lower levels in accessible tissues. Previously described patients with the same mutation also showed congenital or late-onset myopathy. Diabetes is frequently associated with both phenotypes and is a clinical clue to the molecular diagnosis.
Assuntos
DNA Mitocondrial/genética , Miopatias Mitocondriais/genética , Mutação Puntual , Cisteína/genética , Deficiência de Citocromo-c Oxidase , Análise Mutacional de DNA/métodos , Complicações do Diabetes/complicações , Complicações do Diabetes/genética , Complexo I de Transporte de Elétrons/metabolismo , Complexo II de Transporte de Elétrons/metabolismo , Complexo III da Cadeia de Transporte de Elétrons/metabolismo , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Miopatias Mitocondriais/complicações , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , RNA de Transferência/genética , Treonina/genéticaRESUMO
A 19-year-old woman complained of life-long exercise intolerance and had chronic lactic acidosis. Neurological examination was normal, but muscle biopsy showed cytochrome c oxidase-positive fibers and marked complex III deficiency. Sequence analysis showed a novel stop-codon mutation (G15761A) in the mitochondrial DNA (mtDNA)-encoded cytochrome b gene, resulting in loss of the last 41 amino acids of the protein. By PCR/restriction fragment-length polymorphism (RFLP) analysis, the G15761A mutation was very abundant (73%) in the patient's muscle, barely detectable (less than 1%) in her urine, and absent in her blood; it was also absent in muscle, urine and blood from the patient's mother. This mutation fulfills all accepted criteria for pathogenicity.
Assuntos
Códon sem Sentido , Grupo dos Citocromos b/genética , Complexo III da Cadeia de Transporte de Elétrons/deficiência , Miopatias Mitocondriais/diagnóstico , Acidose Láctica/diagnóstico , Acidose Láctica/etiologia , Adulto , Biópsia , Doença Crônica , DNA Mitocondrial/genética , Complexo III da Cadeia de Transporte de Elétrons/genética , Tolerância ao Exercício/genética , Feminino , Humanos , Miopatias Mitocondriais/complicações , Miopatias Mitocondriais/patologia , Músculo Esquelético/enzimologia , Músculo Esquelético/patologia , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Deleção de SequênciaRESUMO
A 3 1/2-year-old boy presented with megaloblastic anemia and recurrent episodes of severe lactic acidosis and coma. At age 4 years, he developed sepsis and died; postmortem examination failed to show any gross abnormality in any tissue. Biochemical analysis of muscle showed decreased activities for all respiratory chain enzymes except complex II. Muscle histochemistry revealed diffuse cytochrome c oxidase deficiency. Southern blot analysis of mitochondrial DNA from muscle, liver, and blood showed a heteroplasmic single mitochindrial DNA deletion of 2.4 kb, which removed the genes for cytochrome c oxidase I and II and the transfer ribonucleic acid genes for serine and aspartic acid. Single large-scale deletions in mitochondrial DNA have been associated with Pearson's syndrome, Kearns-Sayre syndrome, and progressive external ophthalmoplegia. This patient's presentation is unusual and suggests an overlap between Pearson's syndrome and Kearns-Sayre syndrome.
Assuntos
Anemia Megaloblástica/genética , Encefalopatias Metabólicas/genética , Deficiência de Citocromo-c Oxidase/genética , DNA Mitocondrial/genética , Doenças Mitocondriais/genética , Deleção de Sequência , Acidose Láctica/genética , Acidose Láctica/metabolismo , Anemia Megaloblástica/complicações , Southern Blotting , Encefalopatias Metabólicas/complicações , Encefalopatias Metabólicas/metabolismo , Pré-Escolar , Coma/genética , Coma/metabolismo , Deficiência de Citocromo-c Oxidase/diagnóstico , Deficiência de Citocromo-c Oxidase/metabolismo , Diagnóstico Diferencial , Evolução Fatal , Humanos , Síndrome de Kearns-Sayre/genética , Fígado/metabolismo , Masculino , Doenças Mitocondriais/diagnóstico , Doenças Mitocondriais/metabolismo , Músculo Esquelético/metabolismo , Recidiva , SepseRESUMO
We describe an 18-year-old man with muscle cramps and recurrent exertional myoglobinuria, without hemolytic anemia or brain dysfunction. Phosphoglycerate kinase (PGK) deficiency was documented in muscle and erythrocytes and molecular analysis of the PGK1 gene identified a novel mutation, T378P. This is the ninth case presenting with isolated myopathy, whereas most other patients show hereditary non-spherocytic hemolytic anemia alone or associated with brain dysfunction, and a few patients have myopathy plus brain involvement. Although the diverse tissue involvement in PGK deficiency remains unclear, all mutations in myopathic patients tend to cluster in the C terminal domain, adjacent to the substrate-binding pocket. This may lead to a failure in the closure of the N terminal and C terminal domains and loss of stability due to lack of inter-domain communication during the catalytic process.
Assuntos
Predisposição Genética para Doença/genética , Músculo Esquelético/enzimologia , Doenças Musculares/enzimologia , Doenças Musculares/genética , Fosfoglicerato Quinase/deficiência , Fosfoglicerato Quinase/genética , Adolescente , Análise Mutacional de DNA , Tolerância ao Exercício/genética , Marcadores Genéticos/genética , Humanos , Masculino , Cãibra Muscular/genética , Debilidade Muscular/enzimologia , Debilidade Muscular/genética , Debilidade Muscular/fisiopatologia , Músculo Esquelético/patologia , Músculo Esquelético/fisiopatologia , Doenças Musculares/fisiopatologia , Mutação/genética , Mioglobinúria/genética , Estrutura Terciária de Proteína/genéticaRESUMO
Single deletions of mitochondrial DNA (mtDNA) are associated with three major clinical conditions: Kearns-Sayre syndrome, a multisystem disorder; Pearson syndrome (PS), a disorder of the hematopoietic system; and progressive external ophthalmoplegia (PEO), primarily affecting the ocular muscles. Typically, single mtDNA deletions are sporadic events, since the mothers, siblings, and offspring of affected individuals are unaffected. We studied a woman who presented with PEO, ptosis, and weakness of pharyngeal, facial, neck, and limb muscles. She had two unaffected children, but another of her children, an infant son, had sideroblastic anemia, was diagnosed with PS, and died at age 1 year. Morphological analysis of a muscle biopsy sample from the mother showed cytochrome c oxidase-negative ragged-red fibers-a typical pattern in patients with mtDNA deletions. Southern blot analysis using multiple restriction endonucleases and probed with multiple mtDNA fragments showed that both the mother and her infant son harbored an identical 5,355-bp single deletion in mtDNA, without flanking direct repeats. The deletion was the only abnormal species of mtDNA identified in both patients, and there was no evidence for duplications. We conclude that, although the vast majority of single large-scale deletions in mtDNA are sporadic, in rare cases, single deletions can be transmitted through the germline.